Clinical trial
Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject
NCT05849883 is registered in ClinicalTrials.gov with PT Kalbe Farma Tbk as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject
- Lead sponsor
- PT Kalbe Farma Tbk
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 10, 2020
- Completion date
- February 3, 2021
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug use